Aurobindo Pharma makes €74mn acquisition in 5 European countries - Highlight Investment Research

Breaking

We are Best advisory company and SEBI Registered Investment Adviser in India, We Provide sure shot call and 100% Research Based Calls to our clients.

Saturday 14 July 2018

Aurobindo Pharma makes €74mn acquisition in 5 European countries

Hyderabad-headquartered Aurobindo Pharma has entered into an agreement with Canadian pharmaceutical company Apotex International to acquire its operations in five European countries the Netherlands, Belgium, Spain, Poland, and Czech Republic. This is in line with Aurobindo’s strategy to expand its business to Eastern Europe.

In Poland, Aurobindo will add significant sales based on the established brand name “APO” as well as a dedicated sales force covering physicians and the pharmacy network. Additionally, in Poland and the Czech Republic, the Indian pharma giant will become one of the top 15 generics (Gx) companies.


STOCK TIPS TODAY

No comments:

Post a Comment